KIRIN Trademark

Trademark Overview


On Tuesday, April 23, 2019, a trademark application was filed for KIRIN with the United States Patent and Trademark Office. The USPTO has given the KIRIN trademark a serial number of 79269305. The federal status of this trademark filing is REGISTERED as of Tuesday, May 18, 2021. This trademark is owned by Kirin Holdings Kabushiki Kaisha (also trading as Kirin Holdings Company, Limited). The KIRIN trademark is filed in the Pharmaceutical Products category with the following description:

Milk ferments for pharmaceutical purposes; collyrium; nasal spray preparations for medical purposes; nasal spray preparations; vaginal pharmaceutical preparations for treating fungal infections; pharmaceutical antitussive-cold preparations; preparations for destroying vermin; fungicides; herbicides; pharmaceutical preparations for the treatment of gastrointestinal diseases, cancer, bacterial skin infections, vitamin deficiencies, intestinal bacteria, influenza, colds, physical disorders, fatigue, anemia, leukopenia, hyperphosphatemia, hyperparathyroidism, leukemia, influenza, HIV, myelodysplastic syndrome, hepatitis virus infection and autoimmune hepatitis; pharmaceutical preparations for mobilization of peripheral blood progenitor cells; pharmaceutical preparations for conditioning treatment prior to hematopoietic stem cell transplantation; medical and veterinary preparations, namely, diagnostic, bacterial, and bacteriological preparations for medical or veterinary purposes; vitamin p...
kirin

General Information


Serial Number79269305
Word MarkKIRIN
Filing DateTuesday, April 23, 2019
Status700 - REGISTERED
Status DateTuesday, May 18, 2021
Registration Number6350506
Registration DateTuesday, May 18, 2021
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements


Goods and ServicesMilk ferments for pharmaceutical purposes; collyrium; nasal spray preparations for medical purposes; nasal spray preparations; vaginal pharmaceutical preparations for treating fungal infections; pharmaceutical antitussive-cold preparations; preparations for destroying vermin; fungicides; herbicides; pharmaceutical preparations for the treatment of gastrointestinal diseases, cancer, bacterial skin infections, vitamin deficiencies, intestinal bacteria, influenza, colds, physical disorders, fatigue, anemia, leukopenia, hyperphosphatemia, hyperparathyroidism, leukemia, influenza, HIV, myelodysplastic syndrome, hepatitis virus infection and autoimmune hepatitis; pharmaceutical preparations for mobilization of peripheral blood progenitor cells; pharmaceutical preparations for conditioning treatment prior to hematopoietic stem cell transplantation; medical and veterinary preparations, namely, diagnostic, bacterial, and bacteriological preparations for medical or veterinary purposes; vitamin preparations, not for pain relief or cosmetic purposes; vitamin substances in the nature of vitamin supplements, not for pain relief or cosmetic purposes; nutritional additives for medical purposes, not for pain relief or cosmetic purposes; medicinal tonics and substitutes therefor, namely, dietary supplements for humans and animals, not for pain relief or cosmetic purposes; calcium pharmaceutical preparations in the nature of calcium supplements, not for pain relief or cosmetic purposes; reagent paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; capsules sold empty for pharmaceuticals; mothproofing paper; lacteal flour for babies; dietary and nutritional supplements in tablet, chewable, powder, capsule, liquid or gel form, not for pain relief or cosmetic purposes; lactic acid bacteria-based food supplements in gel, tablet, chewable, powder, capsule or liquid form, not for pain relief or cosmetic purposes; dietary and nutritional supplements, not for pain relief or cosmetic purposes; dietetic pharmaceuticals, namely, dietetic foods and beverages adapted for medical or veterinary use; dietetic food adapted for medical purposes, namely, food for chewing and swallowing disorders; food thickener for dysphagia for medical purposes, namely, food additives in the nature of glucose and lecithin for medical purposes for assistance with swallowing; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies, namely, dietary supplement beverages for aiding sleep and promoting digestion for babies; food for babies; nutritional supplements for animal foodstuffs, not for pain relief or cosmetic purposes; dietary supplements for animals, not for pain relief or cosmetic purposes; semen for artificial insemination; cultures of microorganisms for medical or veterinary use
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKirin Holdings Kabushiki Kaisha (also trading as Kirin Holdings Company, Limited)
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameKirin Holdings Kabushiki Kaisha (also trading as Kirin Holdings Company, Limited)
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameKirin Holdings Kabushiki Kaisha (also trading as Kirin Holdings Company, Limited)
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Wednesday, October 16, 2019ASSIGNED TO EXAMINER
Thursday, October 10, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, October 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 21, 2019NON-FINAL ACTION WRITTEN
Tuesday, October 22, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, October 22, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 6, 2019REFUSAL PROCESSED BY MPU
Wednesday, November 6, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 22, 2019REFUSAL PROCESSED BY IB
Wednesday, May 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 6, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 6, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 6, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, May 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 11, 2020ASSIGNED TO LIE
Thursday, June 11, 2020NON-FINAL ACTION E-MAILED
Monday, May 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 11, 2020NON-FINAL ACTION WRITTEN
Thursday, June 11, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 10, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 10, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, March 1, 2021NOTIFICATION PROCESSED BY IB
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 10, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, August 18, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, March 10, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, March 27, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, May 18, 2021REGISTERED-PRINCIPAL REGISTER
Friday, May 23, 2025NEW REPRESENTATIVE AT IB RECEIVED
Sunday, October 24, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, September 1, 2021GENERIC MADRID TRANSACTION CREATED
Wednesday, September 1, 2021GENERIC MADRID TRANSACTION SENT TO IB